NCT01260389

Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.

Pharmaceutical Care for COPD Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 734 (actual)
• Sponsor: University Hospital, Ghent · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

This study would like to test the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in Chronic Obstructive Pulmonary Disease (COPD) patients over a 3 month-period.

Detailed description

Effective pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) not only involves prescription of recommended medicines by the physician, but also implies correct use of the prescribed medication by the patient (ie, good drug adherence and correct inhalation technique). Community pharmacists could help to improve the latter aspect, by delivering pharmaceutical care. The present randomised controlled trial will study the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in COPD patients over a 3 month-period.

Conditions

• Chronic Obstructive Pulmonary Disease (COPD)

Interventions

Type	Name	Description
BEHAVIORAL	pharmaceutical care intervention	Pharmaceutical care intervention, focused at improving inhalation technique and drug adherence in patients with Chronic Obstructive Pulmonary Disease (COPD).

Timeline

• Start date: 2010-12-01
• Primary completion: 2011-05-01
• Completion: 2011-07-01
• First posted: 2010-12-15
• Last updated: 2021-07-13

Locations

2 sites across 1 country: Belgium